Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SOLARA ACTIVE PHARMA SCIENCES Gains 5%; BSE HEALTHCARE Index Down 0.3%
Wed, 25 Sep 9:49

SOLARA ACTIVE PHARMA SCIENCES Gains 5%; BSE HEALTHCARE Index Down 0.3%Image source: Chunumunu/www.istockphoto.com

SOLARA ACTIVE PHARMA SCIENCES share price has zoomed 5% and is presently trading at Rs 819.4.

Meanwhile, the BSE HEALTHCARE index is at 44,111.1 (down 0.3%).

Among the top gainers in the BSE HEALTHCARE index today are Jubilant Pharmova (up 1.7%) and Biocon (up 1.1%).

ASTRAZENECA PHARMA (down 3.8%) and MAX HEALTHCARE INSTITUTE (down 3.3%) are among the top losers today.

Over the last one year, SOLARA ACTIVE PHARMA SCIENCES has moved up from Rs 325.1 to Rs 819.4, registering a gain of Rs 494.3 (up 152.0%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,800.9 to 44,111.1, registering a gain of 58.7% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 185.6%), SUVEN PHARMACEUTICALS (up 124.5%) and Glenmark Pharma (up 115.6%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 84,948.1 .

The top gainers among the BSE Sensex today are Power Grid Corp. (up 2.8%) and M&M (up 2.4%). The most traded stocks in the BSE Sensex are HDFC Bank and Tata Steel.

In the meantime, NSE Nifty is at 25,939.5 . Tata Consumer Products and Tech Mahindra are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,023.7 to 84,948.1, registering a gain of 18,924.4 points (up 28.7%).

SOLARA ACTIVE PHARMA SCIENCES Financial Update...

SOLARA ACTIVE PHARMA SCIENCES net profit grew 29.6% YoY to Rs -135 million for the quarter ended June 2024, compared to a loss of Rs 191 million a year ago. Net sales rose 3.2% to Rs 3,635 million during the period as against Rs 3,523 million in April-June 2023.

For the year ended March 2023, SOLARA ACTIVE PHARMA SCIENCES reported 61.8% increase in net profit to Rs -223 million compared to net loss of Rs 583 million during FY22. Revenue of the company grew 13.8% to Rs 14,438 million during FY23.

The current Price to earnings ratio of SOLARA ACTIVE PHARMA SCIENCES, based on rolling 12 month earnings, stands at -7.0.


Equitymaster requests your view! Post a comment on "SOLARA ACTIVE PHARMA SCIENCES Gains 5%; BSE HEALTHCARE Index Down 0.3%". Click here!